Funded Project Details - FY2021
|Title:|| Retinal Ganglion Cell Differentiation and Transplantation|
||Palo Alto, CA
|Congressional District Code:
||Biomedical Laboratory R&D
|| January 2017 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Optic nerve degenerations as seen in glaucoma, ischemic and traumatic optic neuropathies, are a leading cause of blindness in the U.S. and worldwide, and are very common in the veteran popuation. They are characterized by loss of retinal ganglion cells (RGCs), which are not replaced by endogenous mechanisms, and thus vision loss is generally irreversible. Cell transplantation therapies provide new hope to protect or even to replace degenerated RGCs and restore visual function. However, little is...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.